Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) serves as a notification to the U.S. Securities and Exchange Commission regarding the submission of its Annual Report on Form 20-F. The report covers the fiscal year ended 31 December 2018 and was filed on 15 March 2019. The filing was issued in accordance with Section 203.01 of the New York Stock Exchange Listed Company Manual.
Key Financial Metrics
The provided text is a procedural announcement and does not contain specific financial data. It does not report revenue, profit, cash flow, margins, debt, or liquidity figures. Investors must refer to the linked Annual Report on Form 20-F for audited financial statements.
Material Changes
The filing text does not disclose any material changes in financial performance or operations compared to prior periods. It solely confirms the availability of the 2018 audited financial statements.
Guidance, Outlook, and Risks
- Forward-Looking Statements: GSK includes a cautionary statement noting that any forward-looking statements or projections are subject to risks and uncertainties that may cause actual results to differ materially.
- Risk Factors: Specific risks are referenced as being detailed under Item 3.D "Risk factors" in the 2018 Annual Report on Form 20-F, but are not listed in this summary text.
- Unusual Items: No unusual items or contingencies are described in this specific filing.
Key Facts for Investor Verification
- Verify the full audited financial statements for the year ended 31 December 2018 in the Form 20-F available at www.gsk.com/corporatereporting or www.sec.gov.
- Note that hard copies of the Annual Report and Notice of Annual General Meeting were expected to be available on or about 2 April 2019.
- Shareholders may request free hard copies of audited statements via Equiniti Limited (UK), BNY Mellon Shareowner Services (US), or the GSK Response Center (US).
- Review Item 3.D of the Form 20-F for a comprehensive list of risk factors affecting forward-looking statements.